Literature DB >> 9638541

Cost of diabetes-related amputations in minorities.

H R Ashry1, L A Lavery, D G Armstrong, D C Lavery, W H van Houtum.   

Abstract

The objective of this study was to identify the direct cost and length of hospitalization of diabetes-related lower extremity amputations among Hispanics, African Americans, non-Hispanic whites, and Asians. The authors used a database from the office of Statewide Planning and Development in California that identified all hospitalizations for lower extremity amputations in the state in 1991. Amputation level was defined by the ICD-9-CM codes 84.11-84.18. The total hospital charges for diabetes-related lower extremity amputations for the state of California in 1991 was $141 million. The mean hospital charge (HC) per patient with all ethnic groups combined was $27,930; and the mean length of stay (LOS) was 15.9 days. African Americans had significantly higher mean charges ($32,383) and longer stays (17.3 days) compared to all other ethnic groups (p < .05). Toe-level amputations had lower HC (p < .05) and LOS (p < .01) than other amputation levels for all race groups. One-quarter of the population received multiple amputations during their hospital stay. These patients incurred significantly higher hospital charges ($44,731) and stayed in the hospital longer (23.4 days) than those receiving only a single amputation. There was a considerable variation in the HC and LOS among ethnic groups by level of amputation. The direct charges reported in this study suggest considerably higher overall direct costs than have been previously reported in the medical literature. The greater burden of disease experienced by African Americans is probably related to their higher amputation cost and longer hospitalization.

Entities:  

Mesh:

Year:  1998        PMID: 9638541     DOI: 10.1016/s1067-2516(98)80108-7

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  13 in total

1.  Diabetes Education, Specialty Care, and Self-Care Advice among Obese African American Women with Type 2 Diabetes.

Authors:  Stephania T Miller; Jennifer Cunningham-Erves; Sylvie A Akohoue
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

Review 2.  Disparities in vascular surgery: is it biology or environment?

Authors:  Louis L Nguyen; Antonia J Henry
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

Review 3.  Disparities in amputations in minorities.

Authors:  Kristin M Lefebvre; Lawrence A Lavery
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

4.  The economic impact of hospitalization for diabetic foot infections in a Caribbean nation.

Authors:  Shamir O Cawich; Shariful Islam; Seetharaman Hariharan; Patrick Harnarayan; Steve Budhooram; Shivaa Ramsewak; Vijay Naraynsingh
Journal:  Perm J       Date:  2014

5.  Experiences with surgical treatment of chronic lower limb ulcers at a tertiary hospital in northwestern Tanzania: a prospective review of 300 cases.

Authors:  Fidelis Mbunda; Mabula D McHembe; Phillipo L Chalya; Peter Rambau; Stephen E Mshana; Benson R Kidenya; Japhet M Gilyoma
Journal:  BMC Dermatol       Date:  2012-09-28

6.  Racial factors and inpatient outcomes among patients with diabetes hospitalized with foot ulcers and foot infections, 2003-2014.

Authors:  Ché Matthew Harris; Aiham Albaeni; Roland J Thorpe; Keith C Norris; Marwan S Abougergi
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

Review 7.  Growth factors for treating diabetic foot ulcers.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Susana Nicola; Daniel Simancas-Racines; Ludovic Reveiz; Patricio Oliva; Jorge Cedeño-Taborda
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

8.  Major limb amputations: a tertiary hospital experience in northwestern Tanzania.

Authors:  Phillipo L Chalya; Joseph B Mabula; Ramesh M Dass; Isdori H Ngayomela; Alphonce B Chandika; Nkinda Mbelenge; Japhet M Gilyoma
Journal:  J Orthop Surg Res       Date:  2012-05-11       Impact factor: 2.359

9.  Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.

Authors:  Sandra Y Silva; Ligia C Rueda; Gustavo A Márquez; Marcos López; Daniel J Smith; Carlos A Calderón; Juan C Castillo; Jaime Matute; Christian F Rueda-Clausen; Arturo Orduz; Federico A Silva; Piyaporn Kampeerapappun; Mahesh Bhide; Patricio López-Jaramillo
Journal:  Trials       Date:  2007-09-26       Impact factor: 2.279

10.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.